Paradromics
TX - AustinBiotechnology
Focus: Paradromics is a pre-revenue neurotechnology company developing brain-computer interfaces (BCIs) to restore communication and motor function in neurological diseases. The company is in early clinical stage with its lead program, Connexus, currently in human trials.
Profile data last refreshed 20h ago · AI intelligence enriched 3w ago
Open Jobs
4-4 this month
Stable — net -4 jobs in 30d
0 added, 4 removed. Backfill posture.
Should You Work at Paradromics?
AI assessmentParadromics suits early-career engineers and neuroscientists willing to take funding/timeline risk for exposure to breakthrough BCI technology and foundational product development.
Why Work Here
- Join a company at the frontier of neurotechnology with recent validation through first long-term human BCI implant (June 2026), offering early-career technical impact in a high-barrier field
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Connexus Brain-Computer Interface
Amyotrophic Lateral SclerosisClinical Trials (1)
NCT07357428Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
N/AHelp build intelligence for Paradromics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.